Quantcast
Last updated on April 19, 2014 at 17:21 EDT

Latest FDA Warning Letter Stories

2014-02-06 16:27:42

NEW YORK, Feb. 6, 2014 /PRNewswire/ -- The nationwide law firm of Bernstein Liebhard LLP is now investigating Anatabloc lawsuit (http://www.consumerinjurylawyers.com/consumer-products/anatabloc-lawsuit/) claims against Star Scientific Inc. (NASDAQ: STSI), Rock Creek Pharmaceuticals, Inc. and GNC Holdings, Inc. (NYSE: GNC), the manufacturers and sellers of Anatabloc dietary supplements. Anatabloc was recently the subject of a warning letter issued by the U.S. Food & Drug...

2014-01-27 12:24:54

NEW YORK, Jan. 27, 2014 /PRNewswire-USNewswire/ -- Practising Law Institute (PLI) has announced the release of their newest title, Pharmaceutical Compliance and Enforcement Answer Book 2014. This valuable new guide provides a comprehensive overview of the regulatory issues faced by the different participants in the pharmaceutical industry. (Logo: http://photos.prnewswire.com/prnh/20120423/DC92468LOGO) Howard L. Dorfman, Vice President and General Counsel at Ferring Pharmaceuticals Inc,...

2013-08-31 23:03:28

The Firm is investigating personal injury claims stemming from the GranuFlo recall on behalf of dialysis patients who experienced cardiac arrest, heart attacks, stroke, sudden cardiac death, or other side effects within 48 hours of a dialysis treatment with GranuFlo or NaturaLyte dialysis concentrates. New York, New York (PRWEB) August 31, 2013 As GranuFlo lawsuits (http://www.granuflodialysislawsuits.com/) filed in the aftermath of Fresenius Medical Care’s recall of GranuFlo and...

2013-08-23 23:21:38

d’Oliveira & Associates is investigating the safety of da Vinci Surgical Robots. The law firm also works with some of the more experienced da Vinci Robot lawyers, who handle these cases, and there are no fees unless a settlement or award is obtained. (PRWEB) August 23, 2013 On July 16, 2013, the Food and Drug Administration (FDA) sent Intuitive Surgical a warning letter about the company’s failure to comply with federal rules and regulations. Specifically, the letter referenced...

2013-08-02 23:01:05

The Firm is currently investigating da Vinci lawsuits on behalf of alleged victims of robotic surgery complications allegedly associated with the da Vinci Surgical System. New York, New York (PRWEB) August 02, 2013 As robotic surgery lawsuits (http://www.davincisurgery-lawsuit.com/) involving the da Vinci Surgical System mount in courts around the country, Bernstein Liebhard LLP notes that the U.S. Food & Drug Administration (FDA) has released the Warning Letter it issued to Intuitive...

2013-05-28 08:29:28

Receives Closeout Letter from FDA MIDDLESEX, N.J., May 28, 2013 /PRNewswire/ -- CorePharma LLC ("CorePharma"), a developer, manufacturer, and marketer of targeted generic prescription pharmaceuticals, announced today that it has addressed the violations contained in its June 2010 Warning Letter issued by the Food and Drug Administration. These corrective actions provide a strong operational foundation for the business and have resulted in the FDA issuing a closeout letter to the...

2013-05-20 08:26:00

WELLINGTON, Fla., May 20, 2013 /PRNewswire/ -- Embark Holdings, Inc. (OTC: EMBK) announces that its wholly owned subsidiary Muscle Warfare, Inc. has passed a recent FDA inspection entitled an EIR (Establishment Inspection Report). The inspection was conducted to confirm that Muscle Warfare had discontinued the use of DMAA as stated in a response letter dated back to May of 2012. The inspection also included a complete facility inspection, which reviewed written and executed standard operating...

2013-03-18 08:30:34

Dietary Supplement Good Manufacturing Practices to Be Held on June 11-12; Dietary Supplement Labeling Takes Place on June 13-14 ALEXANDRIA, Va., March 18, 2013 /PRNewswire/ -- EAS Consulting Group, a leader in providing quality regulatory consulting services in all FDA-related matters, is pleased to announce two trainings on dietary supplements in Salt Lake City. The Dietary Supplement Good Manufacturing Practices (GMPs) and Dietary Supplement Labeling regulations will take place...

2013-03-15 23:04:10

The Firm is offering GranuFlo recall lawsuit evaluations to dialysis patients who experienced cardiac arrest, heart attacks, stroke, sudden cardiac death, or other side effects within 48 hours of a dialysis treatment with GranuFlo or NaturaLyte dialysis concentrates. New York, New York (PRWEB) March 15, 2013 As GranuFlo lawsuits related to Fresenius´ recent recall of GranuFlo and NaturaLyte dialysis concentrates continue to mount, the company is facing more problems with the U.S. Food...